IDEXX Laboratories Retained Earnings (Accumulated Deficit) 2010-2024 | IDXX

IDEXX Laboratories retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $5.116B, a 20.38% increase year-over-year.

  • IDEXX Laboratories retained earnings (accumulated deficit) for 2023 were $4.445B, a 23.48% increase from 2022.
  • IDEXX Laboratories retained earnings (accumulated deficit) for 2022 were $3.6B, a 23.25% increase from 2021.
  • IDEXX Laboratories retained earnings (accumulated deficit) for 2021 were $2.92B, a 34.24% increase from 2020.

IDEXX Laboratories Retained Earnings (Accumulated Deficit) 2010-2024 | IDXX

  • IDEXX Laboratories retained earnings (accumulated deficit) for 2023 were $4.445B, a 23.48% increase from 2022.
  • IDEXX Laboratories retained earnings (accumulated deficit) for 2022 were $3.6B, a 23.25% increase from 2021.
  • IDEXX Laboratories retained earnings (accumulated deficit) for 2021 were $2.92B, a 34.24% increase from 2020.